跳至主要内容
临床试验/NL-OMON22531
NL-OMON22531尚未招募不适用

Hypnotherapy for adolescents and adults with Inflammatory bowel disease and symptoms compatible with Irritable bowel syndrome: A randomized controlled trial.

Academic Medical Center (AMC)0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
80

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with inflammatory bowel disease and IBS-like symptoms, age >11 years will be recruited. Patients have to be in remission of their inflammatory bowel disease as defined as no signs of inflammatory bowel disease, low inflammatory markers in laboratory tests and no disease activity on imaging studies of the intestine. IBS-like symptoms are defined as abdominal pain for at least two months, fulfilling the pediatric or adult Rome-III criteria for IBS.

排除标准

  • Exclusion criteria are a concomitant organic gastrointestinal disease, stenotic IBD, complicated IBD that had required surgery more than once, another coexisiting complicated disease (e.g. malignancy, unstable cardiovascular, hepatic or renal disease), treatment by another health care professional for abdominal symptoms, mental retardation, insufficient knowledge of the Dutch language and previous hypnotherapy treatment.

研究者

发起方
Academic Medical Center (AMC)

相似试验